IDO1 and neoplasm: Another effective approach involves the use of hybrid micelles (SK/siIDO1-HMs) for the delivery of shikonin and siRNA targeting IDO-1 knockdown, which have shown promising results in suppressing Tregs in the tumor microenvironment [87].